tiprankstipranks
Advertisement
Advertisement

QNRX Stock Latest News

Quoin Pharmaceuticals Shareholders Approve Governance and Compensation Changes
Company AnnouncementsQuoin Pharmaceuticals Shareholders Approve Governance and Compensation Changes
4d ago
8K
QNRX
Quoin Pharmaceuticals reports Q2 EPS ($1.90), consensus ($1.77)
PremiumThe Fly
Quoin Pharmaceuticals reports Q2 EPS ($1.90), consensus ($1.77)
9d ago
QNRX
QNRX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
QNRX Upcoming Earnings Report: What to Expect?
13d ago
QNRX
Quoin Pharmaceuticals announces FDA clearance of QRX003 IND application
PremiumThe Fly
Quoin Pharmaceuticals announces FDA clearance of QRX003 IND application
2M ago
QNRX
Quoin Pharmaceuticals receives notice of allowance for QRX003 patent
PremiumThe Fly
Quoin Pharmaceuticals receives notice of allowance for QRX003 patent
2M ago
QNRX
Naz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
PremiumRatingsNaz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
2M ago
QNRX
Quoin Advances QYLEKI Toward First Netherton Therapy
Premium
Company Announcements
Quoin Advances QYLEKI Toward First Netherton Therapy
2M ago
8K
QNRX
Quoin Pharmaceuticals announces conditional FDA approval for Qyleki brand name
Premium
The Fly
Quoin Pharmaceuticals announces conditional FDA approval for Qyleki brand name
2M ago
QNRX
Quoin Pharmaceuticals completes establishment of subsidiary in Japan
PremiumThe Fly
Quoin Pharmaceuticals completes establishment of subsidiary in Japan
2M ago
QNRX
Quoin reports positive pediatric data in Netherton Syndrome program
PremiumThe Fly
Quoin reports positive pediatric data in Netherton Syndrome program
2M ago
QNRX
Quoin Pharmaceuticals initiated with a Buy at ThinkEquity
PremiumThe Fly
Quoin Pharmaceuticals initiated with a Buy at ThinkEquity
2M ago
QNRX
Quoin Wins Japan Orphan Drug Status for QRX003
PremiumCompany Announcements
Quoin Wins Japan Orphan Drug Status for QRX003
3M ago
8K
QNRX
Quoin Pharmaceuticals granted Orphan Drug Designation for QRX003 in Japan
PremiumThe FlyQuoin Pharmaceuticals granted Orphan Drug Designation for QRX003 in Japan
3M ago
QNRX
Quoin Pharmaceuticals submits QRX003 IND application to FDA
Premium
The Fly
Quoin Pharmaceuticals submits QRX003 IND application to FDA
3M ago
QNRX
Quoin Pharmaceuticals initiated with a Buy at Lucid Capital
Premium
The Fly
Quoin Pharmaceuticals initiated with a Buy at Lucid Capital
4M ago
QNRX
Quoin Pharmaceuticals provides regulatory update on QRX009 topical rapamycin
PremiumThe Fly
Quoin Pharmaceuticals provides regulatory update on QRX009 topical rapamycin
4M ago
QNRX
Quoin’s QRX003 Trial Moves Forward In Rare Skin Disease, Keeping QNRX On Investor Watch
PremiumCompany Announcements
Quoin’s QRX003 Trial Moves Forward In Rare Skin Disease, Keeping QNRX On Investor Watch
4M ago
QNRX
Financing Covenants Put Quoin Pharmaceuticals at Heightened Risk of Funding Shortfall and Program Delays
PremiumCompany Announcements
Financing Covenants Put Quoin Pharmaceuticals at Heightened Risk of Funding Shortfall and Program Delays
5M ago
QNRX
Quoin Pharmaceuticals price target raised to $35 from $25 at Alliance Global
PremiumThe Fly
Quoin Pharmaceuticals price target raised to $35 from $25 at Alliance Global
5M ago
QNRX
Quoin Pharmaceuticals Ltd – ADR trading resumes
PremiumThe FlyQuoin Pharmaceuticals Ltd – ADR trading resumes
5M ago
QNRX
Quoin Pharmaceuticals Ltd – ADR trading halted, volatility trading pause
Premium
The Fly
Quoin Pharmaceuticals Ltd – ADR trading halted, volatility trading pause
5M ago
QNRX
Quoin Pharmaceuticals provides update following QRX003 Type C meeting with FDA
Premium
The Fly
Quoin Pharmaceuticals provides update following QRX003 Type C meeting with FDA
5M ago
QNRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >